Ron Wyden, AP Images

Af­ter ad­mon­ish­ing Ab­b­Vie for Hu­mi­ra patent and pric­ing, Sen Ron Wyden takes Richard Gon­za­lez to task on tax prac­tices

Lit­tle has changed since Sen­a­tor Ron Wyden (D-OR) ad­mon­ished Ab­b­Vie CEO Richard Gon­za­lez at a Sen­ate Fi­nance Com­mit­tee hear­ing for guard­ing the Hu­mi­ra fran­chise with a thick­et of patents like “Gol­lum with his ring” — and bag­ging hefty bonus­es along the way. In fact, ac­cord­ing to a re­cent re­port from the House Over­sight Com­mit­tee, the price of the drug is now 470% high­er than when it first en­tered the mar­ket.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.